Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Barter

Showing results (331-340 of 390) with videos related to

Pageof 39
Sort By:
American Journal of Human Genetics|November 23, 2024
The methylomic landscape of human articular cartilage development contains epigenetic signatures of osteoarthritis riskEuan McDonnell, Sarah E Orr, Matthew J Barter, et al.
Atherosclerosis|January 21, 2018
The relationship of circulating fibroblast growth factor 21 levels with incident atrial fibrillation: The Multi-Ethnic Study of AtherosclerosisTsz Him Hui, Robyn L McClelland, Matthew A Allison, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 13, 2014
Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus AtorvastatinRishi Puri, Steven E Nissen, Mingyuan Shao, et al.
JACC. Cardiovascular Imaging|September 22, 2014
Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURNRishi Puri, Steven E Nissen, Mingyuan Shao, et al.
Annals of the Rheumatic Diseases|April 10, 2014
Protection against murine osteoarthritis by inhibition of the 26S proteasome and lysine-48 linked ubiquitinationMarta Radwan, David J Wilkinson, Wang Hui, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Epigenetic mechanisms of osteoarthritis risk in human skeletal developmentEuan McDonnell, Sarah E Orr, Matthew J Barter, et al.
Circulation|September 18, 2013
C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapyRishi Puri, Steven E Nissen, Peter Libby, et al.
Journal of the American College of Cardiology|March 18, 2014
Elevated plasma PCSK9 level is equally detrimental for patients with nonfamilial hypercholesterolemia and heterozygous familial hypercholesterolemia, irrespective of low-density lipoprotein receptor defectsGilles Lambert, Francine Petrides, Mathias Chatelais, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 28, 2009
Role of 3beta-hydroxysteroid-delta 24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cellsK C Y McGrath, X H Li, R Puranik, et al.
Atherosclerosis|September 4, 2007
Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South AfricaVivienne M Homer, A David Marais, Francesca Charlton, et al.
Pageof 39

Showing results (331-340 of 390) with videos related to

Sort By:
Pageof 39
American Journal of Human Genetics|November 23, 2024
The methylomic landscape of human articular cartilage development contains epigenetic signatures of osteoarthritis riskEuan McDonnell, Sarah E Orr, Matthew J Barter, et al.
Atherosclerosis|January 21, 2018
The relationship of circulating fibroblast growth factor 21 levels with incident atrial fibrillation: The Multi-Ethnic Study of AtherosclerosisTsz Him Hui, Robyn L McClelland, Matthew A Allison, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 13, 2014
Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus AtorvastatinRishi Puri, Steven E Nissen, Mingyuan Shao, et al.
JACC. Cardiovascular Imaging|September 22, 2014
Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURNRishi Puri, Steven E Nissen, Mingyuan Shao, et al.
Annals of the Rheumatic Diseases|April 10, 2014
Protection against murine osteoarthritis by inhibition of the 26S proteasome and lysine-48 linked ubiquitinationMarta Radwan, David J Wilkinson, Wang Hui, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Epigenetic mechanisms of osteoarthritis risk in human skeletal developmentEuan McDonnell, Sarah E Orr, Matthew J Barter, et al.
Circulation|September 18, 2013
C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapyRishi Puri, Steven E Nissen, Peter Libby, et al.
Journal of the American College of Cardiology|March 18, 2014
Elevated plasma PCSK9 level is equally detrimental for patients with nonfamilial hypercholesterolemia and heterozygous familial hypercholesterolemia, irrespective of low-density lipoprotein receptor defectsGilles Lambert, Francine Petrides, Mathias Chatelais, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 28, 2009
Role of 3beta-hydroxysteroid-delta 24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cellsK C Y McGrath, X H Li, R Puranik, et al.
Atherosclerosis|September 4, 2007
Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South AfricaVivienne M Homer, A David Marais, Francesca Charlton, et al.
Pageof 39